Skip to content
  • Tuesday, 2 June 2026
  • 2:12 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • New Study Reveals Oral Semaglutide Outperforms Orforglipron in Weight Loss and Tolerability
Pharmaceutical R&D

New Study Reveals Oral Semaglutide Outperforms Orforglipron in Weight Loss and Tolerability

Teuku Ryan May 15, 2026 0

Findings presented at the 33rd European Congress on Obesity in Istanbul, Turkey, on May 15th, have provided a crucial comparative…

Read More
Pharmaceutical R&D

Biopharma Leaders Urge Dr. Richard Pazdur to Lead FDA Amidst Crisis of Confidence

Teuku Ryan May 15, 2026 0

The leadership void at the U.S. Food and Drug Administration (FDA) has prompted a significant groundswell of support from the…

Read More
Pharmaceutical R&D

AstraZeneca’s Targeted Treatment Offers New Hope for Stomach Cancer Patients in the UK

Teuku Ryan May 15, 2026 0

AstraZeneca’s groundbreaking targeted therapy, Imfinzi (durvalumab), has secured a pivotal recommendation from the National Institute for Health and Care Excellence…

Read More
Pharmaceutical R&D

Wes Streeting Resigns as UK Health Secretary Citing Loss of Faith in Labour Leadership Following Local Election Debacle

Teuku Ryan May 15, 2026 0

The political landscape of the United Kingdom has been significantly reshaped by the dramatic resignation of Wes Streeting, the UK…

Read More
Pharmaceutical R&D

Foundayo Demonstrates Efficacy in Sustaining Weight Loss Post-Injectable Incretin Therapy, Presenting a Novel Oral Option

Teuku Ryan May 14, 2026 0

On May 13, 2024, at the 33rd European Congress on Obesity (ECO) held in Istanbul, Türkiye, groundbreaking Phase 3b trial…

Read More
Pharmaceutical R&D

FDA Approves Four Groundbreaking Cancer Drugs in May, Offering New Hope for Hematological and Solid Tumors

Teuku Ryan May 14, 2026 0

The U.S. Food and Drug Administration (FDA) has authorized four significant new cancer drugs in May 2026, marking a pivotal…

Read More
Pharmaceutical R&D

Isomorphic Labs Secures $2.1 Billion in Series B Funding to Accelerate AI-Driven Drug Discovery and Development

Teuku Ryan May 14, 2026 0

AI drug design and development firm Isomorphic Labs has successfully closed a significant $2.1 billion Series B funding round, marking…

Read More
Pharmaceutical R&D

UAE Becomes First Nation to Approve AstraZeneca’s Baxfendy for Uncontrolled Hypertension

Teuku Ryan May 14, 2026 0

The United Arab Emirates has achieved a significant milestone in pharmaceutical innovation with the Emirates Drug Establishment (EDE) granting regulatory…

Read More
Pharmaceutical R&D

Novel Combination Therapy CagriSema Demonstrates Promising Results in Obesity Management with Preserved Muscle Strength

Teuku Ryan May 13, 2026 0

On 12 May 2026, at the 33rd European Congress on Obesity (ECO) in Istanbul, Türkiye, groundbreaking findings from the Phase…

Read More
Pharmaceutical R&D

EU Strikes Landmark Deal on Critical Medicines Act to Fortify Pharmaceutical Sector and Ensure Patient Supply

Teuku Ryan May 13, 2026 0

The European Union (EU) has achieved a significant legislative milestone with the provisional agreement on the Critical Medicines Act (CMA),…

Read More

Posts pagination

1 … 5 6 7 … 23
University of California San Francisco Researchers Discover Lungs Play Vital Role in Blood Production and Harbor Life-Saving Stem CellsUCSF Researchers Discover the Lung as a Vital Hub for Blood Production and Stem Cell ReservoirsUCLA and UCSF Researchers Uncover Genetic Mechanisms Behind Neuronal Resistance to Tau Protein Buildup in Alzheimer’s DiseaseScientists just unlocked a cheaper way to make clean hydrogen fuel
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveHigh-Dimensional Topological Structures Discovered in Entangled Photons Offer New Framework for Quantum Information StabilityWater-in-Diesel Emulsion Technology Offers Significant Emissions Reduction Potential Without Engine Modification
Johns Hopkins Study Reveals Significant Heart Tissue Weakening and Arrhythmia Risk in Low Gravity EnvironmentsInsilico CEO sees potentially $2.75 billion collaboration as ‘fusing Lilly’s clinical excellence’ with Insilico’s ‘end-to-end AI engine’Breaking the Barriers of Language Acquisition Experts Debunk Five Common Myths Preventing Adult LearningBreakthrough Low-Temperature Perovskite Catalyst Offers Path to Affordable and Scalable Green Hydrogen Production
YOU MAY HAVE MISSED
Stem Cell & Regenerative Medicine
Johns Hopkins Study Reveals Significant Heart Tissue Weakening and Arrhythmia Risk in Low Gravity Environments
Dwi Wanna Jun 2, 2026
Laboratory Automation & Robotics
Insilico CEO sees potentially $2.75 billion collaboration as ‘fusing Lilly’s clinical excellence’ with Insilico’s ‘end-to-end AI engine’
Lana Keisha Jun 2, 2026
Neuroscience & Brain Research
Breaking the Barriers of Language Acquisition Experts Debunk Five Common Myths Preventing Adult Learning
Rifan Muazin Jun 2, 2026
Advanced Materials Science
Breakthrough Low-Temperature Perovskite Catalyst Offers Path to Affordable and Scalable Green Hydrogen Production
Nila Kartika Wati Jun 2, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ